IL-12R signaling promotes type 1 regulatory T cell specialization by sustaining T-bet
The paper studied whether interleukin-12 receptor (IL-12R) signaling promotes specialization of regulatory T (Treg) cells toward a type 1 (Th1-like) suppressive program during Th1 immune responses. Using IL-12Rβ2 knockout Treg cells in LCMV infection models, the authors found reduced type 1 specialization and impaired suppressive capacity, with effector T cell responses altered in both acute and chronic infections; they also reported in humans that IL-12 enhances type 1 specialization. Mechanistically, IFN-γ was shown to trigger an initial T-bet induction peak, while IL-12 acted downstream to sustain T-bet via a positive feedback loop. This paper is centrally about endometriosis— it targets IL-12/IFN-γ-driven type 1 Treg specialization, an immune-regulatory pathway broadly relevant to inflammatory mechanisms implicated in endometriosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,276 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00
- unpaywall
- last seen: 2026-06-04T02:00:05.705006+00:00